(Q43830961)

27 November 2017

title

Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study (English)

1 reference

27 November 2017

1

Paul Mitchell

1 reference

27 November 2017

Jie Jin Wang

2

1 reference

27 November 2017

Suriya Foran

series ordinal

3

1 reference

27 November 2017

Wayne Smith

series ordinal

4

1 reference

27 November 2017

publication date

1 June 2002

1 reference

27 November 2017

1 reference

27 November 2017

volume

109

1 reference

27 November 2017

issue

6

1 reference

27 November 2017

page(s)

1092-1097

1 reference

Blind registrations in Western Australia: a five-year study.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901055-2

7 January 2021

Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901055-2

7 January 2021

Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901055-2

7 January 2021

The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901055-2

7 January 2021

Seven year follow-up of age-related maculopathy in an elderly British population

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901055-2

7 January 2021

Drusen and Disciform Macular Detachment and Degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901055-2

7 January 2021

Prognosis of Patients with Bilateral Macular Drusen

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901055-2

7 January 2021

Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901055-2

7 January 2021

Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901055-2

7 January 2021

The Wisconsin age-related maculopathy grading system

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901055-2

7 January 2021

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901055-2

7 January 2021

Changes in visual acuity in a population. The Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901055-2

7 January 2021

Smoking and age-related maculopathy. The Blue Mountains Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901055-2

7 January 2021

"Smoking is a major cause of blindness"

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901055-2

7 January 2021

Senile disciform macular degeneration in the second eye.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901055-2

7 January 2021

The second eye of patients with senile macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901055-2

7 January 2021

Second eye involvement in age-related macular degeneration: a four-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901055-2

7 January 2021

Choroidal neovascularization in second eyes of patients with unilateral exudative age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901055-2

7 January 2021

More pieces for the age-related macular degeneration puzzle

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901055-2

7 January 2021

10.1016/S0161-6420(02)01055-2

Identifiers

DOI

1 reference

27 November 2017

1 reference